 Esperion Therapeutics Inc. ESPR , Financial calls itself the Lipid Management Company, a pharmaceutical company focused on developing and commercializing affordable, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol, or LDL-C also known as bad cholesterol. The company was established by Lipitor founder Dr. Roger Newton in 2008 to develop cholesterol-lowering medicines. 